These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 24316393

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure.
    Tang WH, Shrestha K, Troughton RW, Borowski AG, Klein AL.
    Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382
    [Abstract] [Full Text] [Related]

  • 11. The effects of endothelial dysfunction and inflammation on slow coronary flow.
    Arı H, Arı S, Erdoğan E, Tiryakioğlu O, Huysal K, Koca V, Bozat T.
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation.
    Canpolat U, Çetin EH, Cetin S, Aydin S, Akboga MK, Yayla C, Turak O, Aras D, Aydogdu S.
    Clin Appl Thromb Hemost; 2016 Jul; 22(5):476-82. PubMed ID: 26139836
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
    Ekmekci A, Güngör B, Özcan KS, Abaci N, Ilhan E, Ekmekci SS, Kemaloğlu T, Osmonov D, Ustek D, Eren M.
    Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
    [Abstract] [Full Text] [Related]

  • 16. The role of adrenergic activity in slow coronary flow and its relationship to TIMI frame count.
    Yazici M, Demircan S, Durna K, Sahin M.
    Angiology; 2007 Sep; 58(4):393-400. PubMed ID: 17652227
    [Abstract] [Full Text] [Related]

  • 17. [Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon].
    Sığırcı S, Sarıkaya R, Keskin K, Yıldız SS, Pilten Güzel S, Çetinkal G, Önur İ, Kılıçkesmez KO.
    Turk Kardiyol Dern Ars; 2019 Jun; 47(4):251-257. PubMed ID: 31219439
    [Abstract] [Full Text] [Related]

  • 18. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT, Selcuk H, Temizhan A, Maden O, Ulupinar H, Baysal E, Ozeke O, Sasmaz A.
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [Abstract] [Full Text] [Related]

  • 19. High sensitive troponin-I in patients with slow coronary flow pattern.
    Erturk M, Caglar FN, Surgit O, Akturk IF, Somuncu U, Akgul O, Kurtar A, Isiksacan N, Caglar IM, Uslu N.
    Kardiol Pol; 2013 Nov; 71(12):1245-50. PubMed ID: 24399583
    [Abstract] [Full Text] [Related]

  • 20. Serum YKL-40 is increased in patients with slow coronary flow.
    Xu Y, Meng HL, Su YM, Chen C, Huang YH, Li XF, Fan MK, Yan YJ, Wu J, Jiang MH, Pan M.
    Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.